These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19470704)

  • 21. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
    Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
    FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
    Andersen B; Omar BA; Rakipovski G; Raun K; Ahrén B
    Eur J Pharmacol; 2015 Oct; 764():189-194. PubMed ID: 26144370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.
    Liu J; Yang K; Yang J; Xiao W; Le Y; Yu F; Gu L; Lang S; Tian Q; Jin T; Wei R; Hong T
    EBioMedicine; 2019 Mar; 41():73-84. PubMed ID: 30827929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
    Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
    Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.
    Grefhorst A; van Dijk TH; Hammer A; van der Sluijs FH; Havinga R; Havekes LM; Romijn JA; Groot PH; Reijngoud DJ; Kuipers F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E829-38. PubMed ID: 15941783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Deletion of the FOXO1-dependent Hepatokine FGF21 Does not Alter Basal Glucose Homeostasis or Lipolysis in Mice.
    Sostre-Colón J; Gavin MJ; Santoleri D; Titchenell PM
    Endocrinology; 2022 May; 163(5):. PubMed ID: 35303074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ingestion of eicosapentaenoic acid in the early stage of social isolation reduces a fibroblast growth factor 21 resistant state independently of body weight in KKA(y) mice.
    Nonogaki K; Yamazaki T; Murakami M; Kaji T
    Biochem Biophys Res Commun; 2015 Aug; 464(2):674-7. PubMed ID: 26187667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.
    Diener JL; Mowbray S; Huang WJ; Yowe D; Xu J; Caplan S; Misra A; Kapur A; Shapiro J; Ke X; Wu X; Bose A; Panza D; Chen M; Beaulieu V; Gao J
    Endocrinology; 2021 Sep; 162(9):. PubMed ID: 33951176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
    Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long-term glycemic control in diabetic ob/ob mice.
    Sørensen H; Brand CL; Neschen S; Holst JJ; Fosgerau K; Nishimura E; Shulman GI
    Diabetes; 2006 Oct; 55(10):2843-8. PubMed ID: 17003351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
    Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.
    Liang Q; Zhong L; Zhang J; Wang Y; Bornstein SR; Triggle CR; Ding H; Lam KS; Xu A
    Diabetes; 2014 Dec; 63(12):4064-75. PubMed ID: 25024372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice.
    Camacho RC; Zafian PT; Achanfuo-Yeboah J; Manibusan A; Berger JP
    Eur J Pharmacol; 2013 Sep; 715(1-3):41-5. PubMed ID: 23831019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice.
    Burcelin R; Kamohara S; Li J; Tannenbaum GS; Charron MJ; Friedman JM
    Diabetes; 1999 Jun; 48(6):1264-9. PubMed ID: 10342814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia.
    Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ
    Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic change of serum FGF21 levels in response to glucose challenge in human.
    Lin Z; Gong Q; Wu C; Yu J; Lu T; Pan X; Lin S; Li X
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1224-8. PubMed ID: 22539584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance.
    Bernardo B; Lu M; Bandyopadhyay G; Li P; Zhou Y; Huang J; Levin N; Tomas EM; Calle RA; Erion DM; Rolph TP; Brenner M; Talukdar S
    Sci Rep; 2015 Jul; 5():11382. PubMed ID: 26153793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.